Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 12329
  • Home
  • Print this page
  • Email this page
Year : 2020  |  Volume : 68  |  Issue : 1  |  Page : 236-238

Rheumatoid factor versus anti - cyclic citrullinated peptide antibody as screening tool for rheumatoid arthritis in an ophthalmic clinic

1 Head of Cornea and Anterior Segment Services, Nirwana Netralaya, Sasaram, Rohtas, Bihar, India
2 Head of Occuloplasty Services, Nirwana Netralaya, Sasaram, Rohtas, Bihar, India
3 Nirwana Netralaya, Sasaram, Rohtas, Bihar, India

Correspondence Address:
Dr. Prabhakar Singh
Head of Cornea and Anterior Segment Services, Nirwana Netralaya, Sasaram, Rohtas - 821 115, Bihar
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ijo.IJO_526_19

Rights and Permissions

Patients with moderate to severe dry eyes are often screened at the Dry Eye Clinic to rule out connective tissue diseases. Rheumatoid factor (RF) is one of the screening tools to rule out rheumatoid arthritis (RA). Patients who turn out positive for the RF are often subjected to anti-CCP antibody evaluation for confirmation of disease. This article tries to highlight 3 cases of negative and anti-CCP antibody positive cases which presented to the ophthalmic clinic, unaware of their systemic status. Though RF is the cheapest modality to screen for RA, it is not always a reliable marker. One should order anti-CCP antibody for patients where suspicion is high, despite RF being normal.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded62    
    Comments [Add]    

Recommend this journal